View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Martial Descoutures ... (+2)
  • Martial Descoutures
  • Oussema Denguir
Martial Descoutures ... (+2)
  • Martial Descoutures
  • Oussema Denguir
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aedifica: Results slightly better, guidance for the combined entity to come in Sept. CM.com: 4Q25 results – no turning point yet. D'Ieteren: Allstate reports bumper 4Q25, touts premium cuts, consensus prudent. Heijmans: Construction cool cat. Proximus: CPaaS peer Twilio 4Q25 results better than expected. Talabat: 4Q25 results, doubling down on investments. Theon International: Preview – a busy year it was.

 PRESS RELEASE

TomTom and AECOM partner to deliver enhanced global infrastructure pla...

TomTom and AECOM partner to deliver enhanced global infrastructure planning and road traffic management AMSTERDAM, Feb. 12, 2026 (GLOBE NEWSWIRE) -- TomTom (), the specialist in mapping and location technology, today announced a new global partnership with AECOM (NYSE: ACM), the trusted global infrastructure leader. Leveraging TomTom’s historic and real-time traffic measures, AECOM will enhance its mobility and infrastructure planning, transport modelling, and traffic systems management and operations on behalf of both public and private sector clients globally. Through the partnership, ...

Thomas J. Schiessle
  • Thomas J. Schiessle

Massiver Sanierungsbedarf, operativ Schuldenabbau - Coverage-Aussetzun...

Wir setzen die Coverage bis auf Weiteres aus. Am 10.02.26 um 22:51 CET meldete GXI per AdHoc die Verschiebung der ursprünglich für den 26.02.26 geplanten Veröffentlichung des Jahres- und des Konzernabschlusses FY 2025 (30.Nov.25). Nach bisherigen Erkenntnissen hätten – laut Pressemeldungen - einzelne Mitarbeiter gegen interne Richtlinien und Bilanzierungsvorschriften verstoßen. Die daraus resultierenden Korrekturen im Konzernabschluss betreffen demnach im Wesentlichen die Erfassung von Umsatz...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Serbia regulation to be litigated at international level. CM.com: Preview FY25. dsm-firmenich: At last! Exor: Stellantis shares fall sharply on €22bn turnaround plan, writeoff. Euronext: 2026 starting strong. Proximus: €275m impairment at Proximus Global

 PRESS RELEASE

Virbac : Déclaration d'actions et de droits de vote 01/2026

Virbac : Déclaration d'actions et de droits de vote 01/2026 DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place cotation : Euronext ParisCompartiment ACode ISIN : FR0000031577 DATENombre total d’actions composant le capital socialNombre total de droits de vote31 janvier 20268 390 660Total brut de droits de vote : 12 704 131Total net* de droits de vote : 12 691 295 Total net* = nombre total de droits de vote attachés au ...

 PRESS RELEASE

Virbac : Declaration of the number of shares and voting rights 01/2026

Virbac : Declaration of the number of shares and voting rights 01/2026 DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial Market Authority – Autorité des Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal number of shares representing the share capitalTotal number of voting rightsJanuary, 31 20268 390 660Gross total of voting rights : 12 704 131Net total* of voting rights : 12 691...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Flow Traders: Preview 4Q25 / Kinepolis: January reassures with US box office revenue up 14% YoY, France visitors up 15% YoY / Lotus Bakeries: Peer Mondelez 4Q25 results / MICC: Peer Mondelez 4Q25 results / RELX / Wolters Kluwer: Anthropic moves into Legal / Signify: Analyst lunch highlights / TomTom: 4Q25 results, bridging a gap / UCB: Evenity sales exceeded US$2.1bn in FY25 as per Amgen

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch